Company: Oisin Biotechnologies
Job title: CSO
Dr. John Lewis is the Chief Science Officer of Oisin Biotechnologies and heads its cancer-fighting platform technology development and clinical research. Dr. Lewis also holds the Frank and Carla Sojonky Chair in Prostate Cancer Research at the University of Alberta. He is an Associate Professor in the Department of Oncology and chairs the Alberta Prostate Cancer Research Initiative. Dr. Lewis has previously founded several biotechnology companies, including Entos Pharmaceuticals, which has developed the innovative lipid nanoparticle gene therapy platform that Oisin is utilizing for clinical development.
Senolytic Gene Therapy in Naturally Aged Mice 2:15 pm
day: Day Two